Are you currently experiencing a gout flare?

The purpose of this study is to evaluate how anakinra relieves pain for patients with acute gout that cannot take non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine. Anakinra is an FDA-approved medication used to treat symptoms of rheumatoid arthritis.

You may qualify for this study if you:

  • Are age 18 or older
  • Have experienced no pain relief from, or are unable to take, medications commonly used to treat gout
  • Experience gout in four or fewer joints

Study participants will receive the study medication and all study-related care at no cost. You may also be reimbursed for travel expenses.

If you are interested in learning more about participating in this study,
please CLICK HERE to contact us via the form provided and a member of
our study team will respond.

Or call (205) 934-1444 or email



Connect with the Arthritis Clinical
Intervention Program

 FacebookFacebook TwitterTwitter YouTubeYouTube
FlickrFlickr          Google PlusGoogle+  
ACIP Recognitions 

Voted a
 "2011-2012 Best Hospital"
by U.S. News & World Report

Arthritis Clinical Intervention Program
1717 6th Avenue South SRC 076
Birmingham, AL 35294-7201
Phone: 205.934.7727
           Fax: 205.975.5554